Search results
Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
GuruFocus.com via Yahoo Finance· 2 days agoOn June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 3 days agoBooster shots improve immunity Pate urges people to stay up to date with COVID-19 vaccines. The...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 6 days agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 7 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 6 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 6 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 4 days agoThe 18,440-square-foot building will house Texas Biomed’s Animal Health Center, the next phase of...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...